Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: Study protocol for a randomized controlled trial

Authors

B. Joseph Elmunzer, Medical University of South Carolina
Steven A. Edmundowicz, Washington University School of Medicine in St. Louis
et al

Journal

Trials

Publication Date

2016

Volume

17

Issue

1

Inclusive Pages

120

First Page

120

Document Type

Open Access Publication

DOI

10.1186/s13063-016-1251-2

Rights and Permissions

Elmunzer, B.J., Serrano, J., Chak, A. et al. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials 17, 120 (2016). https://doi.org/10.1186/s13063-016-1251-2 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Recommended Citation

Elmunzer, B. Joseph; Edmundowicz, Steven A.; and et al, "Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: Study protocol for a randomized controlled trial." Trials. 17, 1. 120.120 (2016).
https://digitalcommons.wustl.edu/open_access_pubs/4871